An adaptive clinical trial design for cocaine use disorder: Extended-release amphetamine salts for early behavioral intervention non-responders is a research paper published in Contemporary Clinical Trials (2020). On theSindex it has a DataRank of 0.315. It has been cited 4 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0.0733
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
NIDA NIH HHS
Grant: K24 DA029647
NIDA NIH HHS
Grant: T32 DA007294
National Institutes of Health
Grant: R01 DA034087, 2013
NIDA NIH HHS
Grant: R01 DA034087
FWCI
0.27
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals